| pubmed-article:3440604 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:3440604 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:3440604 | lifeskim:mentions | umls-concept:C0304925 | lld:lifeskim |
| pubmed-article:3440604 | lifeskim:mentions | umls-concept:C0029393 | lld:lifeskim |
| pubmed-article:3440604 | lifeskim:mentions | umls-concept:C0009361 | lld:lifeskim |
| pubmed-article:3440604 | lifeskim:mentions | umls-concept:C0220901 | lld:lifeskim |
| pubmed-article:3440604 | lifeskim:mentions | umls-concept:C0086476 | lld:lifeskim |
| pubmed-article:3440604 | lifeskim:mentions | umls-concept:C1522609 | lld:lifeskim |
| pubmed-article:3440604 | lifeskim:mentions | umls-concept:C1554112 | lld:lifeskim |
| pubmed-article:3440604 | lifeskim:mentions | umls-concept:C1883167 | lld:lifeskim |
| pubmed-article:3440604 | pubmed:issue | 6 | lld:pubmed |
| pubmed-article:3440604 | pubmed:dateCreated | 1988-4-13 | lld:pubmed |
| pubmed-article:3440604 | pubmed:abstractText | 367 patients treated on the intensive care unit were prospectively documented during a 1-year observation period. Plasma colloid osmotic pressure (COP) was daily measured. Human albumin therapy was required only in 10% of all patients. These mainly long-term (greater than 10 days) treated patients also showed the lowest levels of COP (minimum COP means: 21 cmH2O (= 15.4 mmHg]. In the majority of all cases an extreme decrease of COP (less than 20 cmH2O (= 14.7 mmHg] was due to sepsis associated with an unfavorable prognosis. 67% of all patients with at least a single decrease of COP less than 20 cmH2O died, as compared to 15% of the patients where the COP never fell below 25 cmH2O. When a low COP was secondary to sepsis, the therapeutic benefit of an albumin therapy could not be evaluated. | lld:pubmed |
| pubmed-article:3440604 | pubmed:language | ger | lld:pubmed |
| pubmed-article:3440604 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3440604 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:3440604 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3440604 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3440604 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:3440604 | pubmed:month | Dec | lld:pubmed |
| pubmed-article:3440604 | pubmed:issn | 0378-0791 | lld:pubmed |
| pubmed-article:3440604 | pubmed:author | pubmed-author:GrundmannRR | lld:pubmed |
| pubmed-article:3440604 | pubmed:author | pubmed-author:TübergenDD | lld:pubmed |
| pubmed-article:3440604 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:3440604 | pubmed:volume | 14 | lld:pubmed |
| pubmed-article:3440604 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:3440604 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:3440604 | pubmed:pagination | 284-8 | lld:pubmed |
| pubmed-article:3440604 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:3440604 | pubmed:meshHeading | pubmed-meshheading:3440604-... | lld:pubmed |
| pubmed-article:3440604 | pubmed:meshHeading | pubmed-meshheading:3440604-... | lld:pubmed |
| pubmed-article:3440604 | pubmed:meshHeading | pubmed-meshheading:3440604-... | lld:pubmed |
| pubmed-article:3440604 | pubmed:meshHeading | pubmed-meshheading:3440604-... | lld:pubmed |
| pubmed-article:3440604 | pubmed:meshHeading | pubmed-meshheading:3440604-... | lld:pubmed |
| pubmed-article:3440604 | pubmed:meshHeading | pubmed-meshheading:3440604-... | lld:pubmed |
| pubmed-article:3440604 | pubmed:meshHeading | pubmed-meshheading:3440604-... | lld:pubmed |
| pubmed-article:3440604 | pubmed:meshHeading | pubmed-meshheading:3440604-... | lld:pubmed |
| pubmed-article:3440604 | pubmed:meshHeading | pubmed-meshheading:3440604-... | lld:pubmed |
| pubmed-article:3440604 | pubmed:meshHeading | pubmed-meshheading:3440604-... | lld:pubmed |
| pubmed-article:3440604 | pubmed:meshHeading | pubmed-meshheading:3440604-... | lld:pubmed |
| pubmed-article:3440604 | pubmed:meshHeading | pubmed-meshheading:3440604-... | lld:pubmed |
| pubmed-article:3440604 | pubmed:meshHeading | pubmed-meshheading:3440604-... | lld:pubmed |
| pubmed-article:3440604 | pubmed:meshHeading | pubmed-meshheading:3440604-... | lld:pubmed |
| pubmed-article:3440604 | pubmed:meshHeading | pubmed-meshheading:3440604-... | lld:pubmed |
| pubmed-article:3440604 | pubmed:meshHeading | pubmed-meshheading:3440604-... | lld:pubmed |
| pubmed-article:3440604 | pubmed:year | 1987 | lld:pubmed |
| pubmed-article:3440604 | pubmed:articleTitle | [Human albumin therapy and prognostic value of determining colloid osmotic pressure at the surgical intensive care station]. | lld:pubmed |
| pubmed-article:3440604 | pubmed:affiliation | Chirurgische Universitätsklinik Köln-Lindenthal. | lld:pubmed |
| pubmed-article:3440604 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:3440604 | pubmed:publicationType | English Abstract | lld:pubmed |
